Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check28 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.10, replacing the previous version v2.16.8. Additionally, a service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check35 days agoChange DetectedThe page has been updated to reflect that there are currently no participants enrolled and the status has changed to 'Withdrawn'. Additionally, the last update date has been revised to July 25, 2025, and the revision number has been updated to v2.16.8.SummaryDifference2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check50 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.